TRAIL Protein, Recombinant human

<strong>TRAIL Protein, Recombinant human</strong>_x000D_ <strong>Catalog number:</strong> B2019346_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 20 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 19.6 kDa_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Apo2 Ligand_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Dianat-Moghadam H, Heidarifard M, Mahari A, Shahgolzari M, Keshavarz M, Nouri M, Amoozgar Z. TRAIL in oncology: From recombinant TRAIL to nano- and self-targeted TRAIL-based therapies Pharmacol Res. 2020 May;155:104716._x000D_ 2: Bohlul E, Hasanlou F, Taromchi AH, Nadri S. TRAIL-expressing recombinant Lactococcus lactis induces apoptosis in human colon adenocarcinoma SW480 and HCT116 cells J Appl Microbiol. 2019 May;126(5):1558-1567._x000D_ 3: Zuch de Zafra CL, Ashkenazi A, Darbonne WC, Cheu M, Totpal K, Ortega S, Flores H, Walker MD, Kabakoff B, Lum BL, Mounho-Zamora BJ, Marsters SA, Dybdal NO. Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkey Cell Death Dis. 2016 Aug 11;7(8):e2338._x000D_ 4: Jung BK, An YH, Jang SH, Ryu G, Jung SB, Kim S, Kim CS, Jang H. The tumor suppressive effect and apoptotic mechanism of TRAIL gene-containing recombinant NDV in TRAIL-resistant colorectal cancer HT-29 cells and TRAIL-nonresistant HCT116 cells, with each cell bearing a mouse model Cancer Med. 2023 Oct;12(20):20380-20395._x000D_ 5: Zhang J, Dong W, Ren Y, Wei D. SAC-TRAIL, a novel anticancer fusion protein: expression, purification, and functional characterization Appl Microbiol Biotechnol. 2022 Feb;106(4):1511-1520._x000D_ 6: Semba M, Takamatsu S, Komazawa-Sakon S, Miyoshi E, Nishiyama C, Nakano H, Moriwaki K. Proscillaridin A Sensitizes Human Colon Cancer Cells to TRAIL-Induced Cell Death Int J Mol Sci. 2022 Jun 23;23(13):6973._x000D_ 7: Yuan X, Gajan A, Chu Q, Xiong H, Wu K, Wu GS. Developing TRAIL/TRAIL death receptor-based cancer therapies Cancer Metastasis Rev. 2018 Dec;37(4):733-748._x000D_ 8: Secchiero P, Rimondi E, di Iasio MG, Agnoletto C, Melloni E, Volpi I, Zauli G. C-Reactive protein downregulates TRAIL expression in human peripheral monocytes via an Egr-1-dependent pathway Clin Cancer Res. 2013 Apr 15;19(8):1949-59._x000D_ 9: De Miguel D, Gallego-Lleyda A, Ayuso JM, Erviti-Ardanaz S, Pazo-Cid R, del Agua C, Fernández LJ, Ochoa I, Anel A, Martinez-Lostao L. TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cells Nanotechnology. 2016 May 6;27(18):185101._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/28455246">10: Prigozhina TB, Szafer F, Aronin A, Tzdaka K, Amsili S, Makdasi E, Shani N, Dranitzki Elhalel M. Fn14·TRAIL fusion protein is oligomerized by TWEAK into a superefficient TRAIL analog Cancer Lett. 2017 Aug 1;400:99-109. </a>_x000D_ _x000D_ <strong>Products Related to TRAIL Protein, Recombinant human can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>